Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study

被引:47
|
作者
Schneider, Karolin [1 ]
Marbaix, Etienne [2 ,3 ]
Bouzin, Caroline [4 ]
Hamoir, Marc [5 ]
Mahy, Pierre [6 ]
Bol, Vanesa [1 ]
Gregoire, Vincent [1 ,7 ]
机构
[1] Catholic Univ Louvain, Ctr Mol Imaging Radiotherapy & Oncol MIRO, Inst Expt & Clin Res IREC, Brussels, Belgium
[2] St Luc Univ Hosp, Dept Pathol, Brussels, Belgium
[3] Catholic Univ Louvain, de Duve Inst, Cell Biol Unit, Brussels, Belgium
[4] Catholic Univ Louvain, Inst Expt & Clin Res IREC, IREC Imaging Platform, Brussels, Belgium
[5] St Luc Univ Hosp, King Albert II Canc Inst, Dept Otorhinolaryngol & Head & Neck Surg, Brussels, Belgium
[6] St Luc Univ Hosp, King Albert II Canc Inst, Dept Stomatol & Maxillofacial Surg, Brussels, Belgium
[7] St Luc Univ Hosp, King Albert II Canc Inst, Dept Radiat Oncol, Brussels, Belgium
关键词
HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; LYMPHOCYTES; PREVALENCE; PROGNOSIS; SURVIVAL; MARKERS; TUMORS;
D O I
10.1080/0284186X.2018.1445287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human papillomavirus (HPV) prevalence in oropharynx squamous cell carcinoma (OPSCC) is on the rise. HPV-linked OPSCCs represent a distinct clinical entity with a better treatment response and patient survival compared to tumors not linked to HPV. An emerging role in treatment response has been attributed to immune cell infiltration in human tumors. In this study, we investigated immune cell infiltration in human SCC of the head and neck region and its relation to overall survival after treatment with surgery (with or without radiotherapy) or concomitant chemo (or cetuximab)-radiotherapy. Materials and methods: Paraffin-embedded tumor samples of 136 patients with SCC of the larynx, hypopharynx, oral cavity and oropharynx were processed for immunohistochemical detection of CD3(+) T-cells, CD8(+) cytotoxic T-cells, CD20(+) B-cells and CD163(+) M2 macrophages within the tumor infiltrated area. Clinico-pathological data were analyzed as a function of tumor location and p16-status. Immune cell infiltration was represented as stained area on the whole tumor infiltrated area, compared for the different tumor locations and correlated to patient survival. Results: Patients with oropharynx tumors expressing significant p16 levels (p16-sg) had a 5-year overall survival of 85% compared to 43% for patients with no significant p16 (p16-ns) expression (HR: 0.3 - 95% CI: 0.1-0.6). Median immune cell infiltration (T- and B-lymphocytes) was significantly elevated in p16-sg oropharyngeal tumors, compared to p16-ns oropharyngeal tumors and to all other head and neck tumor locations. No difference in CD163(+) macrophage infiltration was observed across the different patient groups. In the whole population, a high infiltration by CD3(+) T-lymphocytes was associated to a significantly (p=.03; HR: 0.6, 95% CI: 0.4-0.97) better overall survival. Conclusion: Oropharynx cancer with significant p16 expression showed an increased overall survival and elevated T- and B-lymphocyte infiltration, which suggests a prognostic relevance of immune cell infiltration.
引用
收藏
页码:1165 / 1172
页数:8
相关论文
共 50 条
  • [21] Predictive Role of NEK6 in Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
    Yang, Zhi-Min
    Liao, Bing
    Yang, Si-Si
    Su, Tong
    Zhang, Jing
    Wang, Wei-Ming
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma
    Wang, Zizhuo
    Yuan, Huangbo
    Huang, Jia
    Hu, Dianxing
    Qin, Xu
    Sun, Chaoyang
    Chen, Gang
    Wang, Beibei
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (01): : 182 - 197
  • [23] Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma
    Liu, Guohong
    Yuan, Chunjue
    Ma, Jiaojiao
    Pan, Yunbao
    Xu, Haibo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma Patients
    Meller, Sebastian
    Van Ellen, Anne
    Gevensleben, Heidrun
    Bicker, Anne
    Hankeln, Thomas
    Gorr, Thomas A.
    Sailer, Verena
    Droege, Freya
    Schroeck, Friederike
    Bootz, Friedrich
    Schroeck, Andreas
    Perner, Sven
    Dietrich, Dimo
    Kristiansen, Glen
    ANTICANCER RESEARCH, 2016, 36 (12) : 6235 - 6241
  • [25] Tumor Biomarkers in Spindle Cell Variant Squamous Cell Carcinoma of the Head and Neck
    Rosko, Andrew J.
    Birkeland, Andrew C.
    Wilson, Kevin F.
    Muenz, Daniel G.
    Bellile, Emily
    Bradford, Carol R.
    McHugh, Jonathan B.
    Spector, Matthew E.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2016, 155 (01) : 106 - 112
  • [26] Machine learning explainability for survival outcome in head and neck squamous cell carcinoma
    Alabi, Rasheed Omobolaji
    Makitie, Antti A.
    Elmusrati, Mohammed
    Almangush, Alhadi
    Ehrsson, Ylva Tiblom
    Laurell, Goran
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2025, 199
  • [27] Deciphering COPS5 influence on immune infiltration and prognosis in head and neck squamous cell carcinoma
    Wan, Yuhang
    Wang, Dujuan
    Yang, Gui
    Liu, Guohong
    Pan, Yunbao
    HELIYON, 2024, 10 (13)
  • [28] Increased Expression of PDGFA Is Associated With Poor Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
    Wang, Kaiqin
    Li, Changya
    Chen, Huarong
    Gu, Ping
    Lu, Jiafeng
    Zhao, Houyu
    Zhuo, Xianlu
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2024, 53 (09) : 584 - 594
  • [29] Diagnostic and prognostic biomarkers in head and neck squamous cell carcinoma
    Lehnerdt, G.
    Hoffmann, T. K.
    Mattheis, S.
    Brandau, S.
    Zeidler, R.
    Lang, S.
    HNO, 2010, 58 (07) : 713 - 725
  • [30] Is pulmonary metastasectomy beneficial in head and neck squamous cell carcinoma? A review of literature
    Subramaniam, N. R.
    Reddy, R.
    Balasubramanian, D.
    Thankappan, K.
    Iyer, S.
    INDIAN JOURNAL OF CANCER, 2017, 54 (01) : 2 - 5